| Insideraktier | 14 045 817 shares |
Insider Sentiment Score
Insider sentiment score hittar de företag som köps av foretagsinsynspersoner.
Det är resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av insiderackumulation. Poängmodellen använder en kombination av nettoantalet insiders som köpt de föregående 90 dagarna, det totala antalet aktier som köpts i procent av aktiekapitalet och det totala antalet aktier som ägs av insiders. Siffran sträcker sig från 0 till 100, med högre siffror som indikerar en högre nivå av ackumulering för sina kamrater, och 50 är genomsnittet.
Uppdateringsfrekvens: Dagligen
Se Insiders Top Picks, som ger en lista över företag med högsta insiderackumulation.
Office Sentiment Score
Officersentiment Score hittar företag som köps av Corporate Officers.
Per definition Corporate Officers är Corporate Insiders, men till skillnad från vissa av de andra Insiders (10 % aktieägare och styrelseledamöter), arbetar ämbetsmän för företaget dagligen och de använder sina egna pengar när de handlar . (10 % aktieägare och styrelseledamöter är ofta fondförvaltare som förvaltar andras pengar.) Som sådan är insideraffärer som görs av tjänstemän mycket mer betydelsefulla och bör behandlas på lämpligt sätt.
Liksom Insider Sentiment Score är Officer Sentiment Score resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av officersackumulering.
Uppdateringsfrekvens: Dagligen
Se insiderns bästa val, vilket ger en lista över företag med högsta insider sentiment.
Viktiga insidernyckeltal
Denna kort visar hur företaget rankas längs olika insidernyckeltal. Procenttilrankningen visar hur detta företag jämförs med andra företag på USA-marknaden. Högre rankingar indikerar bättre situationer.
Till exempel anses det allmänt att insiderköp är en positiv indikator, så företag med mer insiderköp skulle rankas högre än företag med mindre insiderköp (eller til och med insiderförsäljning).
Nettoantalet insiders som köper (rankning)
N/A
Nettoantalet insiders som köper är den totala mängden insiders som säljer minus det totala antalet insiders som säljer under de senaste 90 dagarna. Percentilrankningen visas här (intervall från 0 till 100%).
Procent av flytande köpta av insiders (ranking)
N/A
Procentandelen av aktier köpta av insiders är det totala antalet aktier som köpts av insiders minus det totala antalet aktier som sålts av insiders under de senaste 90 dagarna, dividerat med det totala antalet aktier och multiplicerat med 100.
Insiderhandelsdiagram
ARCA biopharma, Inc. insideraffärer visas i följande diagram. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. I allmänhet är det i allmänhet olagligt för insiders att göra affärer i sina företag baserat på väsentlig, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4.
Insiderlista och lönsamhetsstatistik
Den här tabellen visar listan över kända insiders och genereras automatiskt från anmälningar som avslöjas till SEC. Förutom namnen, den senaste titeln och direktören, tjänstemannen eller ägarbeteckningen på 10 %, tillhandahåller vi de senaste avslöjade innehaven. Dessutom, när det är möjligt tillhandahåller vi insiderns historiska handelsresultat. Det historiska handelsresultatet är ett vägt genomsnitt av resultatet för faktiska köptransaktioner på den öppna marknaden som insidern gjort. För mer information om hur detta beräknas, titta på detta YouTube-webinarium.
See our leaderboard of most profitable insider traders.
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|
Report errors via our new Insider Auditing Tool
Track Records av insiderköp - Kortsiktig vinstanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i ABIO / ARCA biopharma, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste köpen på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Track Records av insiderförsäljning - Kortsiktig förlustanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i ABIO / ARCA biopharma, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste försäljningarna på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Transaktionshistorik
Klicka på länkikonen för att se hela transaktionshistoriken. Transaktioner som rapporteras som en del av en automatisk handelsplan 10b5-1 kommer att ha ett X i kolumnen markerad 10b-5.
| Fil datum |
Handel datum |
Schema | Insider | Ticker | Värdepappertitel | Kod | Direkta | Utövningspris | Enhet pris |
Enheter ändrad |
Värde ändrad (1K) |
Kvarvarande Optioner |
Kvarvarande Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-19 | 2025-09-17 | 4 | Fairmount Funds Management LLC By Fairmount Healthcare Fund II L.P. | ORKA | Common Stock | I | 15,0000 | 333 340 | 5 000 | 1 131 954 | ||||
| 2025-07-01 | 3 | Sandler Laura Lee | ORKA | Common Stock | D | 213 084 | ||||||||
| 2025-02-27 | 3 | Venrock Healthcare Capital Partners III, L.P. By Funds | ORKA | Common Stock | I | 4 025 546 | ||||||||
| 2025-02-27 | 2025-02-14 | 4 | Venrock Healthcare Capital Partners III, L.P. By Funds | ORKA | Common Stock | I | 11,4400 | 88 794 | 1 016 | 4 148 428 | ||||
| 2025-02-27 | 2025-02-13 | 4 | Venrock Healthcare Capital Partners III, L.P. By Funds | ORKA | Common Stock | I | 11,6300 | 14 950 | 174 | 4 059 634 | ||||
| 2025-02-27 | 2025-02-12 | 4 | Venrock Healthcare Capital Partners III, L.P. By Funds | ORKA | Common Stock | I | 11,8600 | 8 971 | 106 | 4 044 684 | ||||
| 2025-02-27 | 2025-02-11 | 4 | Venrock Healthcare Capital Partners III, L.P. By Funds | ORKA | Common Stock | I | 10,9500 | 9 593 | 105 | 4 035 713 | ||||
| 2025-02-27 | 2025-02-10 | 4 | Venrock Healthcare Capital Partners III, L.P. By Funds | ORKA | Common Stock | I | 10,9000 | 574 | 6 | 4 026 120 | ||||
| 2024-11-21 | 2024-11-19 | 4 | Fairmount Funds Management LLC By Fairmount Healthcare Fund II L.P. | ORKA | Common Stock | I | 160 000 | 798 614 | ||||||
| 2024-09-13 | 2024-09-11 | 4 | Fairmount Funds Management LLC By Fairmount Healthcare Fund II L.P. | ORKA | Common Stock | I | 23,0000 | 275 000 | 6 325 | 638 614 | ||||
| 2024-09-06 | 3 | Fairmount Funds Management LLC By Fairmount Healthcare Co-Invest III L.P. | ORKA | Common Stock | I | 2 573 308 | ||||||||
| 2024-09-06 | 3 | Fairmount Funds Management LLC By Fairmount Healthcare Fund II L.P. | ORKA | Common Stock | I | 363 614 | ||||||||
| 2024-09-06 | 3 | Turtle Cameron By Turtle Family Trust | ORKA | Common Stock | I | 85 233 | ||||||||
| 2024-09-06 | 3 | Klein Lawrence Otto | ORKA | Common Stock | D | 852 338 | ||||||||
| 2024-08-20 | 2024-08-16 | 4 | JANUS HENDERSON GROUP PLC By Fund | ABIO | Common Stock | I | 2,9768 | 428 | 1 | 2 117 213 | ||||
| 2024-08-20 | 2024-08-16 | 4 | JANUS HENDERSON GROUP PLC By Fund | ABIO | Common Stock | I | 2,9300 | 5 390 | 16 | 2 116 785 | ||||
| 2024-07-26 | 2024-07-25 | 4 | JANUS HENDERSON GROUP PLC By Fund | ABIO | Common Stock | I | 3,0533 | 30 227 | 92 | 2 111 395 | ||||
| 2024-07-26 | 2024-07-24 | 4 | JANUS HENDERSON GROUP PLC By Fund | ABIO | Common Stock | I | 3,1573 | 7 056 | 22 | 2 081 168 | ||||
| 2024-07-26 | 2024-07-24 | 4 | JANUS HENDERSON GROUP PLC By Fund | ABIO | Common Stock | I | 3,1795 | 17 800 | 57 | 2 074 112 | ||||
| 2024-07-26 | 2024-07-24 | 4 | JANUS HENDERSON GROUP PLC By Fund | ABIO | Common Stock | I | 3,2000 | 165 000 | 528 | 2 056 312 | ||||
| 2024-07-12 | 2024-07-11 | 4 | JANUS HENDERSON GROUP PLC By Fund | ABIO | Common Stock | I | 3,4516 | 94 537 | 326 | 1 891 312 | ||||
| 2024-07-12 | 2024-07-10 | 4 | JANUS HENDERSON GROUP PLC By Fund | ABIO | Common Stock | I | 3,4632 | 21 963 | 76 | 1 796 775 | ||||
| 2024-07-12 | 2024-07-10 | 4 | JANUS HENDERSON GROUP PLC By Fund | ABIO | Common Stock | I | 3,4647 | 33 500 | 116 | 1 774 812 | ||||
| 2024-07-12 | 2024-07-09 | 4 | JANUS HENDERSON GROUP PLC By Fund | ABIO | Common Stock | I | 3,4339 | 16 917 | 58 | 1 741 312 | ||||
| 2024-07-12 | 2024-07-08 | 4 | JANUS HENDERSON GROUP PLC By Fund | ABIO | Common Stock | I | 3,5350 | 17 600 | 62 | 1 724 395 | ||||
| 2024-07-12 | 2024-07-08 | 4 | JANUS HENDERSON GROUP PLC By Fund | ABIO | Common Stock | I | 3,4114 | 29 892 | 102 | 1 706 795 | ||||
| 2024-07-12 | 2024-07-05 | 4 | JANUS HENDERSON GROUP PLC By Fund | ABIO | Common Stock | I | 3,4100 | 5 000 | 17 | 1 676 903 | ||||
| 2024-07-12 | 2024-07-05 | 4 | JANUS HENDERSON GROUP PLC By Fund | ABIO | Common Stock | I | 3,4303 | 23 326 | 80 | 1 671 903 | ||||
| 2024-07-12 | 2024-07-03 | 4 | JANUS HENDERSON GROUP PLC By Fund | ABIO | Common Stock | I | 3,5507 | 166 042 | 590 | 1 648 577 | ||||
| 2024-07-12 | 3 | JANUS HENDERSON GROUP PLC By Fund | ABIO | Common Stock | I | 1 482 535 | ||||||||
| 2022-12-19 | 2022-12-16 | 4 | Funicular Funds, LP | ABIO | Common Stock | D | 2,5000 | 1 420 000 | 3 550 | 4 000 452 | ||||
| 2022-12-09 | 2022-12-08 | 4 | Dekker C. Jeffrey | ABIO | Common Stock | D | 40 000 | 40 000 | ||||||
| 2022-12-09 | 2022-12-08 | 4 | Keuer Thomas A | ABIO | Common Stock | D | 40 000 | 40 730 | ||||||
| 2022-07-08 | 2022-07-01 | 4 | Funicular Funds, LP | ABIO | Common Stock | D | 2 580 452 | 2 580 452 | ||||||
| 2022-07-08 | 2022-07-01 | 4 | Funicular Funds, LP By the Funicular Fund, LP | ABIO | Common Stock | I | −2 580 452 | 2 580 452 | ||||||
| 2022-07-08 | 3 | Funicular Funds, LP By Funicular Funds, LP | ABIO | Common Stock | I | 2 580 452 | ||||||||
| 2022-06-21 | 3 | Ma-Weaver Jacob By the Funicular Fund | ABIO | Common Stock | I | 2 580 452 | ||||||||
| 2022-05-25 | 2022-05-25 | 4 | Funicular Fund, LP | ABIO | Common Stock | D | 2,3244 | 64 851 | 151 | 2 580 452 | ||||
| 2022-05-25 | 2022-05-24 | 4 | Funicular Fund, LP | ABIO | Common Stock | D | 2,2851 | 18 110 | 41 | 2 515 601 | ||||
| 2022-05-25 | 2022-05-23 | 4 | Funicular Fund, LP | ABIO | Common Stock | D | 2,2950 | 2 301 | 5 | 2 497 491 | ||||
| 2022-05-20 | 2022-05-19 | 4 | Funicular Fund, LP | ABIO | Common Stock | D | 2,2500 | 1 | 0 | 2 495 190 | ||||
| 2022-05-20 | 2022-05-18 | 4 | Funicular Fund, LP | ABIO | Common Stock | D | 2,3046 | 13 072 | 30 | 2 495 189 | ||||
| 2022-05-16 | 2022-05-16 | 4 | Funicular Fund, LP | ABIO | Common Stock | D | 2,2987 | 42 914 | 99 | 2 482 117 | ||||
| 2022-05-16 | 2022-05-13 | 4 | Funicular Fund, LP | ABIO | Common Stock | D | 2,2942 | 14 000 | 32 | 2 439 203 | ||||
| 2022-05-16 | 2022-05-12 | 4 | Funicular Fund, LP | ABIO | Common Stock | D | 2,2698 | 27 922 | 63 | 2 425 203 | ||||
| 2022-05-11 | 2022-05-11 | 4 | Funicular Fund, LP | ABIO | Common Stock | D | 2,2850 | 24 596 | 56 | 2 397 281 | ||||
| 2022-05-11 | 2022-05-10 | 4 | Funicular Fund, LP | ABIO | Common Stock | D | 2,2845 | 20 979 | 48 | 2 372 685 | ||||
| 2022-05-09 | 2022-05-09 | 4 | Funicular Fund, LP | ABIO | Common Stock | D | 2,2698 | 49 221 | 112 | 2 351 706 | ||||
| 2022-05-09 | 2022-05-06 | 4 | Funicular Fund, LP | ABIO | Common Stock | D | 2,2827 | 57 998 | 132 | 2 302 485 | ||||
| 2022-05-09 | 2022-05-05 | 4 | Funicular Fund, LP | ABIO | Common Stock | D | 2,2747 | 16 903 | 38 | 2 244 487 | ||||
| 2022-05-02 | 2022-05-02 | 4 | Funicular Fund, LP | ABIO | Common Stock | D | 2,3150 | 1 259 | 3 | 2 227 584 | ||||
| 2022-05-02 | 2022-04-29 | 4 | Funicular Fund, LP | ABIO | Common Stock | D | 2,3004 | 8 974 | 21 | 2 226 325 | ||||
| 2022-05-02 | 2022-04-28 | 4 | Funicular Fund, LP | ABIO | Common Stock | D | 2,3169 | 23 381 | 54 | 2 217 351 | ||||
| 2022-04-27 | 2022-04-25 | 4 | Funicular Fund, LP | ABIO | Put Option (obligation to buy) | D | 2,50 | 64,0000 | −7 500 | −480 | 14 500 | |||
| 2022-04-27 | 2022-04-25 | 4 | Funicular Fund, LP | ABIO | Common Stock | D | 2,2913 | 13 751 | 32 | 2 193 970 | ||||
| 2022-04-20 | 2022-04-19 | 4 | Funicular Fund, LP | ABIO | Put Option (obligation to buy) | D | 2,50 | 64,0000 | −7 000 | −448 | 7 000 | |||
| 2022-04-20 | 2022-04-18 | 4 | Funicular Fund, LP | ABIO | Common Stock | D | 2,3117 | 9 119 | 21 | 2 180 219 | ||||
| 2022-04-14 | 2022-04-14 | 4 | Funicular Fund, LP | ABIO | Common Stock | D | 2,3289 | 17 410 | 41 | 2 171 100 | ||||
| 2022-04-12 | 2022-04-12 | 4 | Funicular Fund, LP | ABIO | Common Stock | D | 2,3214 | 69 398 | 161 | 2 153 690 | ||||
| 2022-04-12 | 2022-04-11 | 4 | Funicular Fund, LP | ABIO | Common Stock | D | 2,3150 | 4 655 | 11 | 2 084 292 | ||||
| 2022-04-12 | 2022-04-08 | 4 | Funicular Fund, LP | ABIO | Common Stock | D | 2,3109 | 30 660 | 71 | 2 079 637 | ||||
| 2022-04-07 | 2022-04-07 | 4 | Funicular Fund, LP | ABIO | Common Stock | D | 2,3208 | 27 450 | 64 | 2 048 977 | ||||
| 2022-04-07 | 2022-04-06 | 4 | Funicular Fund, LP | ABIO | Common Stock | D | 2,2981 | 26 806 | 62 | 2 021 527 | ||||
| 2022-04-07 | 2022-04-05 | 4 | Funicular Fund, LP | ABIO | Common Stock | D | 2,3019 | 49 728 | 114 | 1 994 721 | ||||
| 2022-04-07 | 2022-04-04 | 4/A | Funicular Fund, LP | ABIO | Common Stock | D | 2,2585 | 122 342 | 276 | 1 944 993 | ||||
| 2022-04-07 | 3/A | Ma-Weaver Jacob | ABIO | Common Stock | D | 1 822 651 | ||||||||
| 2022-04-04 | 2022-04-04 | 4 | Funicular Fund, LP | ABIO | Common Stock | D | 2,2585 | 122 342 | 276 | 1 944 993 | ||||
| 2022-04-04 | 3 | Funicular Fund, LP | ABIO | Common Stock | D | 1 822 651 | ||||||||
| 2021-12-16 | 2021-12-14 | 4 | Ozeroff Christopher David | ABIO | Stock Option (right to buy) | D | 2,29 | 27 500 | 27 500 | |||||
| 2021-12-16 | 2021-12-14 | 4 | Keuer Thomas A | ABIO | Stock Option (right to buy) | D | 2,29 | 35 000 | 35 000 | |||||
| 2021-12-16 | 2021-12-14 | 4 | BRISTOW MICHAEL R | ABIO | Stock Option (right to buy) | D | 2,29 | 95 000 | 95 000 | |||||
| 2021-12-16 | 2021-12-14 | 4 | Dekker C. Jeffrey | ABIO | Stock Option (right to buy) | D | 2,29 | 17 700 | 17 700 | |||||
| 2021-11-23 | 2021-11-22 | 4 | Ozeroff Christopher David | ABIO | Common Stock | D | 2,2642 | 50 000 | 113 | 50 970 | ||||
| 2021-05-13 | 2021-05-12 | 4 | CONWAY ROBERT E | ABIO | Common Stock | D | 3,1947 | 10 000 | 32 | 50 000 | ||||
| 2021-05-06 | 2021-05-05 | 4 | CONWAY ROBERT E | ABIO | Common Stock | D | 3,2345 | 10 000 | 32 | 40 000 | ||||
| 2021-01-13 | 2021-01-12 | 4 | Hove Anders D | ABIO | Stock Option (right to buy) | D | 4,31 | 12 000 | 12 000 | |||||
| 2021-01-13 | 2021-01-12 | 4 | Grais Linda S | ABIO | Stock Option (right to buy) | D | 4,31 | 12 000 | 12 000 | |||||
| 2021-01-13 | 2021-01-12 | 4 | Woosley Raymond L. | ABIO | Stock Option (right to buy) | D | 4,31 | 12 000 | 12 000 | |||||
| 2021-01-13 | 2021-01-12 | 4 | MITCHELL DANIEL J | ABIO | Stock Option (right to buy) | D | 4,31 | 12 000 | 12 000 | |||||
| 2021-01-13 | 2021-01-12 | 4 | CONWAY ROBERT E | ABIO | Stock Option (right to buy) | D | 4,31 | 12 000 | 12 000 | |||||
| 2020-12-23 | 2020-12-21 | 4 | Keuer Thomas A | ABIO | Stock Option (right to buy) | D | 4,27 | 70 000 | 70 000 | |||||
| 2020-12-23 | 2020-12-21 | 4 | BRISTOW MICHAEL R | ABIO | Stock Option (right to buy) | D | 4,27 | 190 000 | 190 000 | |||||
| 2020-12-23 | 2020-12-21 | 4 | Selby Brian L. | ABIO | Stock Option (right to buy) | D | 4,27 | 55 000 | 55 000 | |||||
| 2020-12-23 | 2020-12-21 | 4 | Ozeroff Christopher David | ABIO | Stock Option (right to buy) | D | 4,27 | 55 000 | 55 000 | |||||
| 2020-12-21 | 2020-12-18 | 4 | CONWAY ROBERT E | ABIO | Common Stock | D | 4,1630 | 10 000 | 42 | 30 000 | ||||
| 2020-09-25 | 2020-09-25 | 4 | CONWAY ROBERT E | ABIO | Common Stock | D | 4,2799 | 5 000 | 21 | 20 000 | ||||
| 2020-09-24 | 2020-09-22 | 4 | CONWAY ROBERT E | ABIO | Common Stock | D | 4,6599 | 3 056 | 14 | 15 000 | ||||
| 2020-09-21 | 2020-09-21 | 4 | CONWAY ROBERT E | ABIO | Common Stock | D | 4,7660 | 10 000 | 48 | 11 944 | ||||
| 2018-04-03 | 2018-04-02 | 4 | Selby Brian L. | ABIO | Common Stock | D | 0,4994 | −1 114 | −1 | 0 | ||||
| 2018-04-03 | 2018-04-03 | 4 | Keuer Thomas A | ABIO | Common Stock | D | 0,5015 | −482 | −0 | 13 153 | ||||
| 2018-03-05 | 2018-03-01 | 4 | Hove Anders D | ABIO | Stock Option (right to buy) | D | 0,72 | 8 000 | 8 000 | |||||
| 2018-03-05 | 2018-03-01 | 4 | MITCHELL DANIEL J | ABIO | Stock Option (right to buy) | D | 0,72 | 8 000 | 8 000 | |||||
| 2018-03-05 | 2018-03-01 | 4 | Grais Linda S | ABIO | Stock Option (right to buy) | D | 0,72 | 8 000 | 8 000 | |||||
| 2018-03-05 | 2018-03-01 | 4 | Woosley Raymond L. | ABIO | Stock Option (right to buy) | D | 0,72 | 8 000 | 8 000 | |||||
| 2018-03-05 | 2018-03-01 | 4 | CONWAY ROBERT E | ABIO | Stock Option (right to buy) | D | 0,72 | 8 000 | 8 000 | |||||
| 2018-03-01 | 2018-02-27 | 4 | Selby Brian L. | ABIO | Common Stock | D | 0,5300 | −161 | −0 | 1 114 | ||||
| 2018-03-01 | 2018-02-28 | 4 | Keuer Thomas A | ABIO | Common Stock | D | 0,7180 | −410 | −0 | 13 635 | ||||
| 2018-02-28 | 2018-02-27 | 4 | VENROCK HEALTHCARE CAPITAL PARTNERS LP By Funds | ABIO | Common Stock | I | 0,5300 | −41 331 | −22 | 0 | ||||
| 2018-02-28 | 2018-02-26 | 4 | VENROCK HEALTHCARE CAPITAL PARTNERS LP By Funds | ABIO | Common Stock | I | 0,5500 | −1 500 000 | −825 | 41 331 | ||||
| 2018-02-27 | 2018-02-26 | 4 | BARRIS PETER J See Note 2 | ABIO | Common Stock | I | 0,5008 | −1 460 209 | −731 | 0 | ||||
| 2018-02-27 | 2018-02-26 | 4 | BASKETT FOREST See Note 2 | ABIO | Common Stock | I | 0,5008 | −1 460 209 | −731 | 0 | ||||
| 2018-02-27 | 2018-02-26 | 4 | Florence Anthony A. Jr. See Note 2 | ABIO | Common Stock | I | 0,5008 | −1 460 209 | −731 | 0 | ||||
| 2018-02-27 | 2018-02-26 | 4 | Viswanathan Ravi See Note 2 | ABIO | Common Stock | I | 0,5008 | −1 460 209 | −731 | 0 | ||||
| 2018-02-27 | 2018-02-26 | 4 | MAKOWER JOSHUA See Note 2 | ABIO | Common Stock | I | 0,5008 | −1 460 209 | −731 | 0 | ||||
| 2018-02-27 | 2018-02-26 | 4 | MOTT DAVID M See Note 2 | ABIO | Common Stock | I | 0,5008 | −1 460 209 | −731 | 0 | ||||
| 2018-02-27 | 2018-02-26 | 4 | Sakoda Jon See Note 2 | ABIO | Common Stock | I | 0,5008 | −1 460 209 | −731 | 0 | ||||
| 2018-02-27 | 2018-02-26 | 4 | SANDELL SCOTT D See Note 2 | ABIO | Common Stock | I | 0,5008 | −1 460 209 | −731 | 0 | ||||
| 2018-02-27 | 2018-02-26 | 4 | Sonsini Peter W. See Note 2 | ABIO | Common Stock | I | 0,5008 | −1 460 209 | −731 | 0 | ||||
| 2018-02-27 | 2018-02-26 | 4 | Growth Equity Opportunities IV, LLC | ABIO | Common Stock | D | 0,5008 | −1 460 209 | −731 | 0 | ||||
| 2017-07-17 | 2017-07-14 | 4 | CONWAY ROBERT E | ABIO | Common Stock | D | 2,4900 | 10 000 | 25 | 35 000 | ||||
| 2017-05-03 | 2017-05-02 | 4 | MITCHELL DANIEL J | ABIO | Common Stock | D | 2,7100 | 11 000 | 30 | 11 000 | ||||
| 2017-04-05 | 2017-04-04 | 4 | BRISTOW MICHAEL R | ABIO | Common Stock | D | 2,4100 | −720 | −2 | 41 155 | ||||
| 2017-04-05 | 2017-04-04 | 4 | Keuer Thomas A | ABIO | Common Stock | D | 2,4100 | −390 | −1 | 14 045 | ||||
| 2017-04-05 | 2017-04-04 | 4 | Ozeroff Christopher David | ABIO | Common Stock | D | 2,4100 | −418 | −1 | 17 517 | ||||
| 2017-04-05 | 2017-04-03 | 4 | Selby Brian L. | ABIO | Common Stock | D | 2,4600 | −1 114 | −3 | 1 275 | ||||
| 2017-03-27 | 2017-03-24 | 4 | CONWAY ROBERT E | ABIO | Common Stock | D | 2,5900 | 25 000 | 65 | 25 000 | ||||
| 2017-03-01 | 2017-02-28 | 4 | Ozeroff Christopher David | ABIO | Common Stock | D | 2,6100 | −465 | −1 | 17 935 | ||||
| 2017-03-01 | 2017-02-27 | 4 | Ozeroff Christopher David | ABIO | Stock Option (right to buy) | D | 2,60 | 22 700 | 22 700 | |||||
| 2017-03-01 | 2017-02-27 | 4 | Selby Brian L. | ABIO | Stock Option (right to buy) | D | 2,60 | 24 100 | 24 100 | |||||
| 2017-03-01 | 2017-02-27 | 4 | Selby Brian L. | ABIO | Common Stock | D | 2,5600 | −161 | −0 | 2 389 | ||||
| 2017-03-01 | 2017-02-28 | 4 | Keuer Thomas A | ABIO | Common Stock | D | 2,6100 | −465 | −1 | 14 435 | ||||
| 2017-03-01 | 2017-02-27 | 4 | Keuer Thomas A | ABIO | Stock Option (right to buy) | D | 2,60 | 23 800 | 23 800 | |||||
| 2017-03-01 | 2017-02-28 | 4 | BRISTOW MICHAEL R | ABIO | Common Stock | D | 2,6100 | −763 | −2 | 41 875 | ||||
| 2017-03-01 | 2017-02-27 | 4 | BRISTOW MICHAEL R | ABIO | Stock Option (right to buy) | D | 2,60 | 41 600 | 41 600 | |||||
| 2017-02-21 | 3 | Hove Anders D By VHCP Co-Investment Holdings, LLC | ABIO | Common Stock | I | 1 612 818 | ||||||||
| 2017-02-21 | 3 | Hove Anders D By Venrock Healthcare Capital Partners, L.P. | ABIO | Common Stock | I | 1 932 243 | ||||||||
| 2017-02-21 | 3 | Hove Anders D By VHCP Co-Investment Holdings, LLC | ABIO | Common Stock | I | 1 612 818 | ||||||||
| 2017-02-21 | 3 | Hove Anders D By Venrock Healthcare Capital Partners, L.P. | ABIO | Common Stock | I | 1 932 243 | ||||||||
| 2017-02-21 | 3 | Hove Anders D By Venrock Healthcare Capital Partners II, L.P. | ABIO | Common Stock | I | 2 308 991 | ||||||||
| 2017-02-21 | 3 | Hove Anders D By VHCP Co-Investment Holdings II, LLC | ABIO | Common Stock | I | 1 852 603 | ||||||||
| 2017-02-21 | 3 | Hove Anders D By Venrock Healthcare Capital Partners II, L.P. | ABIO | Common Stock | I | 2 308 991 | ||||||||
| 2017-02-21 | 3 | Hove Anders D By VHCP Co-Investment Holdings II, LLC | ABIO | Common Stock | I | 1 852 603 | ||||||||
| 2017-02-21 | 2017-02-16 | 4 | Grais Linda S | ABIO | Stock Option (right to buy) | D | 2,50 | 8 000 | 8 000 | |||||
| 2017-02-21 | 2017-02-16 | 4 | CONWAY ROBERT E | ABIO | Stock Option (right to buy) | D | 2,50 | 8 000 | 8 000 | |||||
| 2017-02-21 | 2017-02-16 | 4 | Ozeroff Christopher David | ABIO | Stock Option (right to buy) | D | 2,50 | 24 000 | 24 000 | |||||
| 2017-02-21 | 2017-02-16 | 4 | Selby Brian L. | ABIO | Stock Option (right to buy) | D | 2,50 | 23 000 | 23 000 | |||||
| 2017-02-21 | 2017-02-16 | 4 | MITCHELL DANIEL J | ABIO | Stock Option (right to buy) | D | 2,50 | 8 000 | 8 000 | |||||
| 2017-02-21 | 2017-02-16 | 4 | Keuer Thomas A | ABIO | Stock Option (right to buy) | D | 2,50 | 25 200 | 25 200 | |||||
| 2017-02-21 | 2017-02-16 | 4 | Hove Anders D | ABIO | Stock Option (right to buy) | D | 2,50 | 10 000 | 10 000 | |||||
| 2017-02-21 | 2017-02-16 | 4 | Woosley Raymond L. | ABIO | Stock Option (right to buy) | D | 2,50 | 8 000 | 8 000 | |||||
| 2017-02-21 | 2017-02-16 | 4 | BRISTOW MICHAEL R | ABIO | Stock Option (right to buy) | D | 2,50 | 42 000 | 42 000 | |||||
| 2016-10-18 | 2016-10-18 | 4 | Keuer Thomas A | ABIO | Common Stock | D | 2,4510 | −483 | −1 | 14 900 | ||||
| 2016-09-21 | 2016-09-19 | 4 | Selby Brian L. | ABIO | Common Stock | D | 2,9100 | −476 | −1 | 2 550 | ||||
| 2016-09-21 | 2016-09-20 | 4 | Ozeroff Christopher David | ABIO | Common Stock | D | 2,8900 | −1 185 | −3 | 18 400 | ||||
| 2016-09-21 | 2016-09-20 | 4 | Keuer Thomas A | ABIO | Common Stock | D | 2,8900 | −714 | −2 | 15 383 | ||||
| 2016-09-21 | 2016-09-20 | 4 | BRISTOW MICHAEL R | ABIO | Common Stock | D | 2,8900 | −1 972 | −6 | 42 638 | ||||
| 2016-06-13 | 2016-06-09 | 4 | Selby Brian L. | ABIO | Stock Option (right to buy) | D | 3,30 | 32 100 | 32 100 | |||||
| 2016-06-13 | 2016-06-09 | 4 | Selby Brian L. | ABIO | Stock Option (right to buy) | D | 3,30 | 15 800 | 15 800 | |||||
| 2016-06-13 | 2016-06-09 | 4 | Ozeroff Christopher David | ABIO | Stock Option (right to buy) | D | 3,30 | 30 200 | 30 200 | |||||
| 2016-06-13 | 2016-06-09 | 4 | Ozeroff Christopher David | ABIO | Stock Option (right to buy) | D | 3,30 | 14 800 | 14 800 | |||||
| 2016-06-13 | 2016-06-09 | 4 | Keuer Thomas A | ABIO | Stock Option (right to buy) | D | 3,30 | 31 700 | 31 700 | |||||
| 2016-06-13 | 2016-06-09 | 4 | Keuer Thomas A | ABIO | Stock Option (right to buy) | D | 3,30 | 15 600 | 15 600 | |||||
| 2016-06-13 | 2016-06-09 | 4 | BRISTOW MICHAEL R | ABIO | Stock Option (right to buy) | D | 3,30 | 55 400 | 55 400 | |||||
| 2016-06-13 | 2016-06-09 | 4 | BRISTOW MICHAEL R | ABIO | Stock Option (right to buy) | D | 3,30 | 27 200 | 27 200 | |||||
| 2016-04-06 | 2016-04-04 | 4 | Selby Brian L. | ABIO | Common Stock | D | 3,5200 | −1 114 | −4 | 3 026 | ||||
| 2016-04-06 | 2016-04-05 | 4 | Ozeroff Christopher David | ABIO | Common Stock | D | 3,5200 | −366 | −1 | 19 585 | ||||
| 2016-04-06 | 2016-04-05 | 4 | Keuer Thomas A | ABIO | Common Stock | D | 3,5200 | −384 | −1 | 16 097 | ||||
| 2016-04-06 | 2016-04-05 | 4 | BRISTOW MICHAEL R | ABIO | Common Stock | D | 3,5200 | −724 | −3 | 44 610 | ||||
| 2016-03-02 | 2016-02-29 | 4 | Selby Brian L. | ABIO | Common Stock | D | 3,4600 | −160 | −1 | 4 140 | ||||
| 2016-03-02 | 2016-03-01 | 4 | BRISTOW MICHAEL R | ABIO | Common Stock | D | 3,5000 | −752 | −3 | 45 334 | ||||
| 2016-03-02 | 2016-03-01 | 4 | Ozeroff Christopher David | ABIO | Common Stock | D | 3,5100 | −458 | −2 | 19 951 | ||||
| 2016-03-02 | 2016-03-01 | 4 | Keuer Thomas A | ABIO | Common Stock | D | 3,5300 | −457 | −2 | 16 481 | ||||
| 2016-02-16 | 2016-02-11 | 4 | CONWAY ROBERT E | ABIO | Stock Option (right to buy) | D | 3,44 | 8 000 | 8 000 | |||||
| 2016-02-16 | 2016-02-11 | 4 | MITCHELL DANIEL J | ABIO | Stock Option (right to buy) | D | 3,44 | 8 000 | 8 000 | |||||
| 2016-02-16 | 2016-02-11 | 4 | Woosley Raymond L. | ABIO | Stock Option (right to buy) | D | 3,44 | 8 000 | 8 000 | |||||
| 2016-02-16 | 2016-02-11 | 4 | Grais Linda S | ABIO | Stock Option (right to buy) | D | 3,44 | 8 000 | 8 000 | |||||
| 2015-10-19 | 2015-10-16 | 4 | Keuer Thomas A | ABIO | Common Stock | D | 5,1400 | −496 | −3 | 16 938 | ||||
| 2015-09-21 | 2015-09-18 | 4 | Selby Brian L. | ABIO | Common Stock | D | 6,2300 | −476 | −3 | 4 300 | ||||
| 2015-09-21 | 2015-09-18 | 4 | Keuer Thomas A | ABIO | Common Stock | D | 6,3300 | −680 | −4 | 17 407 | ||||
| 2015-09-21 | 2015-09-18 | 4 | BRISTOW MICHAEL R | ABIO | Common Stock | D | 6,3300 | −1 809 | −11 | 46 086 | ||||
| 2015-09-21 | 2015-09-18 | 4 | Ozeroff Christopher David | ABIO | Common Stock | D | 6,3200 | −1 129 | −7 | 20 409 | ||||
| 2015-06-17 | 3 | Sonsini Peter W. See Note 1 | ABIO | Common Stock | I | 20 442 930 | ||||||||
| 2015-06-17 | 3 | Sonsini Peter W. See Note 1 | ABIO | Common Stock | I | 20 442 930 | ||||||||
| 2015-06-17 | 3 | MAKOWER JOSHUA See Note 1 | ABIO | Common Stock | I | 20 442 930 | ||||||||
| 2015-06-17 | 3 | MAKOWER JOSHUA See Note 1 | ABIO | Common Stock | I | 20 442 930 | ||||||||
| 2015-06-17 | 3 | NEA 15 GP, LLC | ABIO | Common Stock | D | 20 442 930 | ||||||||
| 2015-06-17 | 3 | NEA 15 GP, LLC | ABIO | Common Stock | D | 20 442 930 | ||||||||
| 2015-06-17 | 3 | NEA 15 GP, LLC | ABIO | Common Stock | D | 20 442 930 | ||||||||
| 2015-06-17 | 3 | NEA 15 GP, LLC | ABIO | Common Stock | D | 20 442 930 | ||||||||
| 2015-06-17 | 3 | NEA 15 GP, LLC | ABIO | Common Stock | D | 20 442 930 | ||||||||
| 2015-06-17 | 3 | Weller Harry R See Note 1 | ABIO | Common Stock | I | 20 442 930 | ||||||||
| 2015-06-17 | 3 | Weller Harry R See Note 1 | ABIO | Common Stock | I | 20 442 930 | ||||||||
| 2015-06-17 | 3 | Viswanathan Ravi See Note 1 | ABIO | Common Stock | I | 20 442 930 | ||||||||
| 2015-06-17 | 3 | Viswanathan Ravi See Note 1 | ABIO | Common Stock | I | 20 442 930 | ||||||||
| 2015-06-17 | 3 | Florence Anthony A. Jr. See Note 1 | ABIO | Common Stock | I | 20 442 930 | ||||||||
| 2015-06-17 | 3 | Florence Anthony A. Jr. See Note 1 | ABIO | Common Stock | I | 20 442 930 | ||||||||
| 2015-06-17 | 3 | MOTT DAVID M See Note 1 | ABIO | Common Stock | I | 20 442 930 | ||||||||
| 2015-06-17 | 3 | MOTT DAVID M See Note 1 | ABIO | Common Stock | I | 20 442 930 | ||||||||
| 2015-06-17 | 3 | BASKETT FOREST See Note 1 | ABIO | Common Stock | I | 20 442 930 | ||||||||
| 2015-06-17 | 3 | BASKETT FOREST See Note 1 | ABIO | Common Stock | I | 20 442 930 | ||||||||
| 2015-06-17 | 3 | Sakoda Jon See Note 1 | ABIO | Common Stock | I | 20 442 930 | ||||||||
| 2015-06-17 | 3 | Sakoda Jon See Note 1 | ABIO | Common Stock | I | 20 442 930 | ||||||||
| 2015-06-17 | 3 | BARRIS PETER J See Note 1 | ABIO | Common Stock | I | 20 442 930 | ||||||||
| 2015-06-17 | 3 | BARRIS PETER J See Note 1 | ABIO | Common Stock | I | 20 442 930 | ||||||||
| 2015-06-17 | 3 | VHCP Management II, LLC By funds | ABIO | Common Stock | I | 21 578 648 | ||||||||
| 2015-06-17 | 3 | VHCP Management II, LLC By funds | ABIO | Common Stock | I | 21 578 648 | ||||||||
| 2015-06-17 | 3 | VHCP Management II, LLC By funds | ABIO | Common Stock | I | 21 578 648 | ||||||||
| 2015-06-17 | 3 | VHCP Management II, LLC By funds | ABIO | Common Stock | I | 21 578 648 | ||||||||
| 2015-06-17 | 3 | VHCP Management II, LLC By funds | ABIO | Common Stock | I | 21 578 648 | ||||||||
| 2015-06-17 | 3 | VHCP Management II, LLC By funds | ABIO | Common Stock | I | 21 578 648 | ||||||||
| 2015-06-17 | 3 | VHCP Management II, LLC By funds | ABIO | Common Stock | I | 21 578 648 | ||||||||
| 2015-06-17 | 3 | VHCP Management II, LLC By funds | ABIO | Common Stock | I | 21 578 648 | ||||||||
| 2015-06-17 | 3 | VHCP Management II, LLC By funds | ABIO | Common Stock | I | 21 578 648 | ||||||||
| 2015-06-17 | 3 | KOLLURI KRISHNA KITTU See Note 1 | ABIO | Common Stock | I | 20 442 930 | ||||||||
| 2015-06-17 | 3 | KOLLURI KRISHNA KITTU See Note 1 | ABIO | Common Stock | I | 20 442 930 | ||||||||
| 2015-06-17 | 3 | SANDELL SCOTT D See Note 1 | ABIO | Common Stock | I | 20 442 930 | ||||||||
| 2015-06-17 | 3 | SANDELL SCOTT D See Note 1 | ABIO | Common Stock | I | 20 442 930 | ||||||||
| 2015-03-02 | 2015-03-02 | 4 | Selby Brian L. | ABIO | Common Stock | D | 0,7110 | −1 125 | −1 | 33 441 | ||||
| 2015-03-02 | 2015-03-02 | 4 | BRISTOW MICHAEL R | ABIO | Common Stock | D | 0,7131 | −5 446 | −4 | 335 279 | ||||
| 2015-02-17 | 2015-02-12 | 4 | Woosley Raymond L. | ABIO | Stock Option (right to buy) | D | 0,67 | 8 000 | 8 000 | |||||
| 2015-02-17 | 2015-02-12 | 4 | Selby Brian L. | ABIO | Stock Option (right to buy) | D | 0,67 | 12 600 | 12 600 | |||||
| 2015-02-17 | 2015-02-12 | 4 | Selby Brian L. | ABIO | Common Stock | D | 23 400 | 34 566 | ||||||
| 2015-02-17 | 2015-02-12 | 4 | CONWAY ROBERT E | ABIO | Stock Option (right to buy) | D | 0,67 | 8 000 | 8 000 | |||||
| 2015-02-17 | 2015-02-12 | 4 | BRISTOW MICHAEL R | ABIO | Stock Option (right to buy) | D | 0,67 | 25 900 | 25 900 | |||||
| 2015-02-17 | 2015-02-12 | 4 | BRISTOW MICHAEL R | ABIO | Common Stock | D | 48 100 | 340 725 | ||||||
| 2015-02-17 | 2015-02-12 | 4 | Keuer Thomas A | ABIO | Stock Option (right to buy) | D | 0,67 | 13 650 | 13 650 | |||||
| 2015-02-17 | 2015-02-12 | 4 | Keuer Thomas A | ABIO | Common Stock | D | 25 350 | 126 626 | ||||||
| 2015-02-17 | 2015-02-12 | 4 | Grais Linda S | ABIO | Stock Option (right to buy) | D | 0,67 | 8 000 | 8 000 | |||||
| 2015-02-17 | 2015-02-12 | 4 | Ozeroff Christopher David | ABIO | Stock Option (right to buy) | D | 0,67 | 12 950 | 12 950 | |||||
| 2015-02-17 | 2015-02-12 | 4 | Ozeroff Christopher David | ABIO | Common Stock | D | 24 050 | 150 787 | ||||||
| 2015-02-17 | 2015-02-12 | 4 | MITCHELL DANIEL J | ABIO | Stock Option (right to buy) | D | 0,67 | 8 000 | 8 000 | |||||
| 2015-01-16 | 2015-01-16 | 4 | mccormack riley See above | ABIO | COMMON STOCK | I | 0,7500 | −100 000 | −75 | 2 100 000 | ||||
| 2015-01-16 | 2015-01-15 | 4 | mccormack riley See above | ABIO | COMMON STOCK | I | 0,7500 | −125 000 | −94 | 2 200 000 | ||||
| 2015-01-16 | 2015-01-14 | 4 | mccormack riley By Self as trustee for Riley McCormack 2011 Rev Trust | ABIO | COMMON STOCK | I | 0,7900 | −125 000 | −99 | 2 325 000 | ||||
| 2015-01-07 | 2015-01-07 | 4 | mccormack riley See above | ABIO | COMMON STOCK | I | 0,8700 | −200 000 | −174 | 2 450 000 | ||||
| 2015-01-07 | 2015-01-06 | 4 | mccormack riley See above | ABIO | COMMON STOCK | I | 0,9200 | −200 000 | −184 | 2 650 000 | ||||
| 2015-01-07 | 2015-01-05 | 4 | mccormack riley By Self as trustee for Riley McCormack 2011 Rev Trust | ABIO | COMMON STOCK | I | 0,9700 | −150 000 | −146 | 2 850 000 | ||||
| 2014-12-30 | 3 | Selby Brian L. | ABIO | Common Stock | D | 22 332 | ||||||||
| 2014-12-30 | 3 | Selby Brian L. | ABIO | Common Stock | D | 22 332 | ||||||||
| 2014-12-30 | 3 | Keuer Thomas A | ABIO | Common Stock | D | 202 552 | ||||||||
| 2014-12-30 | 3 | Keuer Thomas A | ABIO | Common Stock | D | 202 552 | ||||||||
| 2014-09-19 | 2014-09-18 | 4 | BRISTOW MICHAEL R | ABIO | Common Stock | D | 1,3000 | −13 853 | −18 | 292 625 | ||||
| 2014-09-19 | 2014-09-18 | 4 | Wheeler Patrick M | ABIO | Common Stock | D | 1,3100 | −8 246 | −11 | 101 510 | ||||
| 2014-03-03 | 2014-02-27 | 4 | BRISTOW MICHAEL R | ABIO | Stock Option (right to buy) | D | 1,95 | 51 500 | 51 500 | |||||
| 2014-03-03 | 2014-02-27 | 4 | BRISTOW MICHAEL R | ABIO | Common Stock | D | 1,9500 | 56 700 | 111 | 306 478 | ||||
| 2014-03-03 | 2014-02-27 | 4 | Ozeroff Christopher David | ABIO | Stock Option (right to buy) | D | 1,95 | 10 500 | 10 500 | |||||
| 2014-03-03 | 2014-02-27 | 4 | Ozeroff Christopher David | ABIO | Common Stock | D | 1,9500 | 34 200 | 67 | 126 737 | ||||
| 2014-03-03 | 2014-02-27 | 4 | Wheeler Patrick M | ABIO | Stock Option (right to buy) | D | 1,95 | 20 500 | 20 500 | |||||
| 2014-03-03 | 2014-02-27 | 4 | Wheeler Patrick M | ABIO | Common Stock | D | 1,9500 | 34 200 | 67 | 109 756 | ||||
| 2014-02-13 | 3 | MITCHELL DANIEL J | ABIO | Common Stock | D | 0 | ||||||||
| 2014-02-13 | 2014-02-11 | 4 | Grais Linda S | ABIO | Stock Option (right to buy) | D | 1,80 | 8 000 | 8 000 | |||||
| 2014-02-13 | 2014-02-11 | 4 | CONWAY ROBERT E | ABIO | Stock Option (right to buy) | D | 1,80 | 8 000 | 8 000 | |||||
| 2014-02-13 | 2014-02-11 | 4 | Woosley Raymond L. | ABIO | Stock Option (right to buy) | D | 1,80 | 8 000 | 8 000 | |||||
| 2014-02-04 | 2014-02-04 | 4 | mccormack riley By Self as Trustee for Riley McCormack 2011 Rev Trust | ABIO | Warrant to purchase common stock | I | 2,12 | 250 000 | 250 000 | |||||
| 2014-02-04 | 2014-02-04 | 4 | mccormack riley By Self as Trustee for Riley McCormack 2011 Rev Trust | ABIO | COMMON STOCK | I | 1,7000 | 1 000 000 | 1 700 | 3 000 000 | ||||
| 2013-10-07 | 3 | mccormack riley | ABIO | Common Stock | D | 2 000 000 | ||||||||
| 2013-09-19 | 2013-09-17 | 4 | Ozeroff Christopher David | ABIO | Stock Option (right to buy) | D | 1,38 | 42 642 | 42 642 | |||||
| 2013-09-19 | 2013-09-17 | 4 | Ozeroff Christopher David | ABIO | Common Stock | D | 1,3800 | 75 000 | 103 | 92 537 | ||||
| 2013-09-19 | 2013-09-17 | 4 | CONWAY ROBERT E | ABIO | Stock Option (right to buy) | D | 1,38 | 2 608 | 2 608 | |||||
| 2013-09-19 | 2013-09-17 | 4 | CONWAY ROBERT E | ABIO | Stock Option (right to buy) | D | 1,38 | 14 750 | 14 750 | |||||
| 2013-09-19 | 2013-09-17 | 4 | Grais Linda S | ABIO | Stock Option (right to buy) | D | 1,38 | 7 417 | 7 417 | |||||
| 2013-09-19 | 2013-09-17 | 4 | Grais Linda S | ABIO | Stock Option (right to buy) | D | 1,38 | 16 000 | 16 000 | |||||
| 2013-09-19 | 2013-09-17 | 4 | BRISTOW MICHAEL R | ABIO | Stock Option (right to buy) | D | 1,38 | 282 825 | 282 825 | |||||
| 2013-09-19 | 2013-09-17 | 4 | BRISTOW MICHAEL R | ABIO | Common Stock | D | 1,3800 | 125 000 | 172 | 249 778 | ||||
| 2013-09-19 | 2013-09-17 | 4 | Woosley Raymond L. | ABIO | Stock Option (right to buy) | D | 1,38 | 3 463 | 3 463 | |||||
| 2013-09-19 | 2013-09-17 | 4 | Woosley Raymond L. | ABIO | Stock Option (right to buy) | D | 1,38 | 14 750 | 14 750 | |||||
| 2013-09-19 | 2013-09-17 | 4 | Wheeler Patrick M | ABIO | Stock Option (right to buy) | D | 1,38 | 81 856 | 81 856 | |||||
| 2013-09-19 | 2013-09-17 | 4 | Wheeler Patrick M | ABIO | Common Stock | D | 1,3800 | 75 000 | 103 | 75 556 | ||||
| 2013-09-19 | 2013-09-17 | 4 | ZABRISKIE JOHN L | ABIO | Stock Option (right to buy) | D | 1,38 | 7 417 | 7 417 | |||||
| 2013-09-19 | 2013-09-17 | 4 | ZABRISKIE JOHN L | ABIO | Stock Option (right to buy) | D | 1,38 | 16 000 | 16 000 | |||||
| 2013-09-04 | 3 | CONWAY ROBERT E | ABIO | Common Stock | D | 0 | ||||||||
| 2013-07-30 | 3 | Woosley Raymond L. | ABIO | Common Stock | D | 0 | ||||||||
| 2013-07-30 | 2013-07-26 | 4 | ZABRISKIE JOHN L | ABIO | Option to Purchase Common Stock (right to buy) | D | 1,40 | 583 | 583 | |||||
| 2013-07-30 | 2013-07-26 | 4 | Grais Linda S | ABIO | Option to Purchase Common Stock (right to buy) | D | 1,40 | 583 | 583 | |||||
| 2013-06-14 | 2013-06-12 | 4 | BRISTOW MICHAEL R | ABIO | Series A Convertible Preferred Stock | D | 160,0000 | −781 | −125 | 0 | ||||
| 2013-06-14 | 2012-06-12 | 4 | BRISTOW MICHAEL R | ABIO | Common Stock | D | 78 100 | 124 778 | ||||||
| 2013-06-06 | 2013-06-04 | 4 | BRISTOW MICHAEL R | ABIO | Common Stock Warrants (right to buy) | D | 1,60 | 39 050 | 39 050 | |||||
| 2013-06-06 | 2013-06-04 | 4 | BRISTOW MICHAEL R | ABIO | Series A Convertible Preferred Stock | D | 160,0000 | 781 | 125 | 781 | ||||
| 2013-01-28 | 2013-01-25 | 4 | BRISTOW MICHAEL R By NFS Custodian for Michael Bristow's IRA | ABIO | Common stock warrants (right to buy) | I | 0,38 | 748 503 | 748 503 | |||||
| 2013-01-28 | 2013-01-25 | 4 | BRISTOW MICHAEL R By NFS Custodian for Michael Bristow's IRA | ABIO | Common Stock | I | 0,4676 | 1 069 290 | 500 | 1 069 290 | ||||
| 2012-12-20 | 2012-12-18 | 4 | BRISTOW MICHAEL R By Investocor Trust, as sole trustee | ABIO | Common stock warrants (right to buy) | I | 0,39 | 387 837 | 387 837 | |||||
| 2012-12-20 | 2012-12-18 | 4 | BRISTOW MICHAEL R By Investocor Trust, as sole trustee | ABIO | Common Stock | I | 0,4835 | 517 116 | 250 | 834 495 | ||||
| 2012-11-02 | 3 | Atlas Venture Associates VII, L.P. | ABIO | Common Stock | D | 1 579 542 | ||||||||
| 2012-10-24 | 2012-10-22 | 4 | FORMELA JEAN FRANCOIS | ABIO | Common Stock Warrants (right to buy) | I | 0,30 | 238 034 | 313 483 | |||||
| 2012-10-24 | 2012-10-22 | 4 | FORMELA JEAN FRANCOIS See Foonote | ABIO | Common Stock | I | 0,3939 | 317 379 | 125 | 1 579 542 | ||||
| 2012-10-24 | 2012-10-22 | 4 | BRISTOW MICHAEL R By Investocor Trust, as sole trustee | ABIO | Common Stock Warrants (right to buy) | I | 0,30 | 238 034 | 238 024 | |||||
| 2012-10-24 | 2012-10-22 | 4 | BRISTOW MICHAEL R By Investocor Trust, as sole trustee | ABIO | Common Stock | I | 0,3939 | 317 379 | 125 | 317 379 | ||||
| 2012-10-24 | 2012-10-22 | 4 | Ozeroff Christopher David | ABIO | Common Stock Warrant (right to buy) | D | 0,30 | 47 606 | 47 606 | |||||
| 2012-10-24 | 2012-10-22 | 4 | Ozeroff Christopher David | ABIO | Common Stock | D | 0,3939 | 63 475 | 25 | 105 233 | ||||
| 2012-10-24 | 2012-10-22 | 4 | ZABRISKIE JOHN L | ABIO | Common Stock Warrants (right to buy) | I | 0,30 | 95 213 | 95 213 | |||||
| 2012-10-24 | 2012-10-22 | 4 | ZABRISKIE JOHN L | ABIO | Common Stock | I | 0,3939 | 126 951 | 50 | 156 131 | ||||
| 2012-02-14 | 2012-02-10 | 4 | FORMELA JEAN FRANCOIS See footnote (1) | ABIO | Option to Purchase Common Stock | I | 1,00 | 3 500 | 3 500 | |||||
| 2012-02-14 | 2012-02-10 | 4 | FORMELA JEAN FRANCOIS See footnote (1) | ABIO | Option to Purchase Common Stock | I | 1,00 | 3 500 | 3 500 | |||||
| 2012-02-14 | 2012-02-10 | 4 | ZABRISKIE JOHN L | ABIO | Option to Purchase Common Stock | D | 1,00 | 3 500 | 3 500 | |||||
| 2012-02-14 | 2012-02-10 | 4 | ZABRISKIE JOHN L | ABIO | Option to Purchase Common Stock | D | 1,00 | 3 500 | 3 500 | |||||
| 2012-02-14 | 2012-02-10 | 4 | SOBEL BURTON E | ABIO | Option to Purchase Common Stock | D | 1,00 | 3 500 | 3 500 | |||||
| 2012-02-14 | 2012-02-10 | 4 | SOBEL BURTON E | ABIO | Option to Purchase Common Stock | D | 1,00 | 3 500 | 3 500 | |||||
| 2012-02-14 | 2012-02-10 | 4 | Grais Linda S | ABIO | Option to Purchase Common Stock | D | 1,00 | 3 500 | 3 500 | |||||
| 2012-02-14 | 2012-02-10 | 4 | Grais Linda S | ABIO | Option to Purchase Common Stock | D | 1,00 | 3 500 | 3 500 | |||||
| 2012-02-14 | 2012-02-10 | 4 | BREWER RICHARD B | ABIO | Option to Purchase Common Stock | D | 1,00 | 3 500 | 3 500 | |||||
| 2012-02-14 | 2012-02-10 | 4 | BREWER RICHARD B | ABIO | Option to Purchase Common Stock | D | 1,00 | 3 500 | 3 500 | |||||
| 2009-12-15 | 3 | Wheeler Patrick M | ABIO | Common Stock | D | 3 338 | ||||||||
| 2009-04-08 | 2009-04-06 | 4 | BOULDER VENTURES IV ANNEX LP By BV Partners IV, LLC | ABIO | Common Stock | I | 31 | 549 | ||||||
| 2009-04-08 | 2009-04-06 | 4 | BOULDER VENTURES IV ANNEX LP By BV Partners IV, LLC | ABIO | Common Stock | I | 518 | 518 | ||||||
| 2009-04-08 | 2009-04-06 | 4 | BOULDER VENTURES IV ANNEX LP By Boulder Ventures IV, L.P. | ABIO | Common Stock | I | −3 292 | 44 715 | ||||||
| 2009-04-08 | 2009-04-06 | 4 | BOULDER VENTURES IV ANNEX LP | ABIO | Common Stock | D | −49 708 | 675 403 | ||||||
| 2009-03-03 | 3 | FALBERG KATHRYN E | ABIO | Common Stock | D | 21 000 | ||||||||
| 2009-03-03 | 2009-02-27 | 4 | PENDERGAST MARY K | ABIO | Option to Purchase Common Stock | D | 5,29 | 7 500 | 7 500 | |||||
| 2009-03-03 | 2009-02-27 | 4 | SOBEL BURTON E | ABIO | Option to Purchase Common Stock | D | 5,29 | 7 500 | 7 500 | |||||
| 2009-03-03 | 2009-02-27 | 4 | LOVE TED W | ABIO | Option to Purchase Common Stock | D | 5,29 | 7 500 | 7 500 | |||||
| 2009-02-05 | 3 | BREWER RICHARD B | ABIO | Common Stock | D | 83 490 | ||||||||
| 2009-02-05 | 3 | BRISTOW MICHAEL R | ABIO | Common Stock | D | 272 677 | ||||||||
| 2009-02-05 | 3 | FORMELA JEAN FRANCOIS | ABIO | Common Stock | I | 1 402 163 | ||||||||
| 2009-02-05 | 3 | FREYTAG J WILLIAM | ABIO | Common Stock | D | 0 | ||||||||
| 2009-02-05 | 3 | Lowe David George | ABIO | Common Stock | I | 877 583 | ||||||||
| 2009-02-05 | 3 | Grais Linda S | ABIO | Common Stock | I | 702 698 | ||||||||
| 2009-02-05 | 3 | Skyline Venture Partners Qualified Purchaser Fund IV L P | ABIO | Common Stock | D | 877 583 | ||||||||
| 2009-02-05 | 3 | Ozeroff Christopher David | ABIO | Common Stock | D | 79 388 | ||||||||
| 2009-02-05 | 3 | St Laurent Randall | ABIO | None | D | 0 | ||||||||
| 2009-02-05 | 3 | Roshko Peter | ABIO | Common Stock | D | 725 111 | ||||||||
| 2009-02-05 | 3 | Roshko Peter By Boulder Ventures IV, L.P. | ABIO | Common Stock | I | 48 007 | ||||||||
| 2009-02-05 | 3 | ZABRISKIE JOHN L | ABIO | Common Stock | I | 29 180 | ||||||||
| 2004-09-02 | 2004-07-30 | 4 | CREDIT SUISSE AG/ | NUVO | Warrants | I | 4,98 | −698 | 0 | |||||
| 2004-09-02 | 2004-07-30 | 4 | CREDIT SUISSE AG/ | NUVO | Warrants | I | 4,98 | −12 562 | 0 | |||||
| 2004-09-02 | 2004-07-30 | 4 | CREDIT SUISSE AG/ | NUVO | Warrants | I | 4,98 | −209 364 | 0 | |||||
| 2004-09-02 | 2004-07-30 | 4 | CREDIT SUISSE AG/ | NUVO | Warrants | I | 4,98 | −18 218 | 0 | |||||
| 2004-09-02 | 2004-07-30 | 4 | CREDIT SUISSE AG/ See footnote(s) | NUVO | Common Stock | I | 4,9800 | 698 | 3 | 7 230 | ||||
| 2004-09-02 | 2004-07-30 | 4 | CREDIT SUISSE AG/ See footnote(s) | NUVO | Common Stock | I | 4,9800 | 12 562 | 63 | 130 088 | ||||
| 2004-09-02 | 2004-07-30 | 4 | CREDIT SUISSE AG/ See footnote(s) | NUVO | Common Stock | I | 4,9800 | 209 364 | 1 043 | 1 215 554 | ||||
| 2004-09-02 | 2004-07-30 | 4 | CREDIT SUISSE AG/ See footnote(s) | NUVO | Common Stock | I | 4,9800 | 18 218 | 91 | 188 667 |
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)
